Low molecular weight heparin and atherosclerosis

被引：0
|
作者：
Hunt D. [1 ]
机构：
[1] Section of General Internal Medicine, Ben Taub General Hospital, Houston, TX 77030
来源：
Current Atherosclerosis Reports | 2004年 / 6卷 / 2期
关键词：
Percutaneous Coronary Intervention; Acute Coronary Syndrome; Enoxaparin; Abciximab; Unfractionated Heparin;
D O I：
10.1007/s11883-004-0103-9
中图分类号：
学科分类号：
摘要：
Low molecular weight heparin (LMWH) has dramatically impacted the treatment of venous thromboembolic disease and acute coronary syndromes. Recent studies help define the role of these agents for patients undergoing percutaneous coronary interventions and for patients treated with thrombolytic agents for ST-segment elevation myocardial infarction. Recent studies also suggest potential usefulness of LMWH for patients with peripheral vascular disease and its limits of utility in stroke. This review summarizes the evidence about the use of LMWH in these clinical situations. Copyright © 2004 by Current Science Inc.
引用
收藏
页码：140 / 147
页数：7
相关论文
共 50 条
  • [1] Low molecular weight heparin
    Vanpee, D
    Gillet, JB
    Swine, C
    ANNALS OF EMERGENCY MEDICINE, 2000, 36 (03) : 277 - 277
  • [2] Heparin and low-molecular-weight heparin
    Gray, Elaine
    Mulloy, Barbara
    Barrowcliffel, Trevor W.
    THROMBOSIS AND HAEMOSTASIS, 2008, 99 (05) : 807 - 818
  • [3] Protective effects of certoparin sodium, a low molecular weight heparin derivative, in experimental atherosclerosis
    Deepa, PR
    Varalakshmi, P
    CLINICA CHIMICA ACTA, 2004, 339 (1-2) : 105 - 115
  • [4] HEPARIN, LOW-MOLECULAR WEIGHT HEPARIN, AND HEPARIN ANALOGS
    THOMAS, DP
    BRITISH JOURNAL OF HAEMATOLOGY, 1984, 58 (03) : 385 - 390
  • [5] Heparin and low molecular weight heparin: background and pharmacology
    Morris, TA
    CLINICS IN CHEST MEDICINE, 2003, 24 (01) : 39 - +
  • [6] Low molecular weight heparin and epidurals
    Crews, JC
    JOURNAL OF CLINICAL MONITORING AND COMPUTING, 1998, 14 (7-8) : 507 - 509
  • [7] Is low molecular weight heparin a neuroprotectant?
    Jonas, S
    Sugimori, M
    Llinas, R
    NEUROPROTECTIVE AGENTS - THIRD INTERNATIONAL CONFERENCE, 1997, 825 : 389 - 393
  • [8] LOW-MOLECULAR-WEIGHT HEPARIN
    WOLF, H
    MEDICAL CLINICS OF NORTH AMERICA, 1994, 78 (03) : 733 - 743
  • [9] Low molecular weight heparin in children
    Albisetti, M
    Andrew, M
    EUROPEAN JOURNAL OF PEDIATRICS, 2002, 161 (02) : 71 - 77
  • [10] LOW-MOLECULAR-WEIGHT HEPARIN
    HIRSH, J
    LEVINE, MN
    BLOOD, 1992, 79 (01) : 1 - 17
12345